United States · FDA National Drug Code directory

Fluticasone Propionate and Salmeterol

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0527-6010_f418af21-42ab-4af0-bc6f-1079059c07fb
Product NDC: 0527-6010
Form: POWDER
Composition / generic term: fluticasone propionate and salmeterol
Labeler: Lannett Company, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20260112
Source listing expiry: 20271231

Source-listed ingredients

SALMETEROL XINAFOATE — 50 ug/1
FLUTICASONE PROPIONATE — 100 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

1 INHALER in 1 CARTON (0527-6010-06) / 60 POWDER in 1 INHALER · 0527-6010-06

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →